Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome

Author： Zhang Wen-Ming Xu Ling-Yun Lu Yan-ming Cao Lan-Fang

ISSN： 0892-3973

Source： Immunopharmacology and Immunotoxicology, Vol.36, Iss.2, 2014-04, pp. : 176-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

By Kalliolias George D C Liossis Stamatis-Nick

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 349-359

Informa Healthcare

Access to resources Recommend Favorite

Tocilizumab reduces disease activity in patients with systemic-onset juvenile idiopathic rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis

By Zhang Xiaoping Morcos Peter N Saito Tomohisa Terao Kimio

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 123-137

Informa Healthcare

Access to resources Recommend Favorite

Juvenile Idiopathic Arthritis: New Insights into Classification, Measures of Outcome, and Pharmacotherapy

By Beresford Michael W.

Pediatric Drugs, Vol. 13, Iss. 3, 2011-06 ,pp. : 161-173

Adis International

Access to resources Recommend Favorite

Treatment strategies for juvenile idiopathic arthritis

By Klein Ariane Horneff Gerd

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 3049-3060

Informa Healthcare

Access to resources Recommend Favorite